IDEAS home Printed from https://ideas.repec.org/a/plo/pone00/0075284.html
   My bibliography  Save this article

Conflicts of Interest among Authors of Clinical Practice Guidelines for Glycemic Control in Type 2 Diabetes Mellitus

Author

Listed:
  • Susan L Norris
  • Haley K Holmer
  • Lauren A Ogden
  • Brittany U Burda
  • Rongwei Fu

Abstract

Background: Conflict of interest (COI) is an important potential source of bias in the development of clinical practice guidelines (CPGs). Objectives: To examine rates of disclosure of COI, including financial interests in companies that manufacture drugs that are recommended in CPGs on glycemic control in type 2 diabetes mellitus, and to explore the relationship between recommendations for specific drugs in a guideline and author COI. Methods: We identified a cohort of relevant guidelines from the National Guideline Clearinghouse (NGC) and abstracted COI disclosures from all guideline authors for this observational, cross-sectional study. We determined which hypoglycemic drugs were recommended in each guideline, and explored the relationship between specific disclosures and whether a drug was recommended. Results: Among 13 included guidelines, the percentage of authors with one or more financial disclosures varied from 0 to 94% (mean 44.2%), and was particularly high for two US-based guidelines (91% and 94%). Three guidelines disclosed no author financial COI. The percentage of authors with disclosures of financial interests in manufacturers of recommended drugs was also high (mean 30%). On average, 56% of manufacturers of patented drugs recommended in each guideline had one or more authors with a financial interest in their company. We did not find a significant relationship between financial interests and whether a drug was recommended in our sample; US-based guidelines were more likely to make recommendations for a specific drug compared to non-US based guidelines. Discussion: Authors of this cohort of guidelines have financial interests directly related to the drugs that they are recommending. Although we did not find an association between author COI and drugs recommended in these guidelines and we cannot draw conclusions about the validity of the recommendations, the credibility of many of these guidelines is in doubt.

Suggested Citation

  • Susan L Norris & Haley K Holmer & Lauren A Ogden & Brittany U Burda & Rongwei Fu, 2013. "Conflicts of Interest among Authors of Clinical Practice Guidelines for Glycemic Control in Type 2 Diabetes Mellitus," PLOS ONE, Public Library of Science, vol. 8(10), pages 1-1, October.
    • Handle: RePEc:plo:pone00:0075284
    DOI: 10.1371/journal.pone.0075284
    as

    Download full text from publisher

    File URL: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0075284
    Download Restriction: no
    File URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0075284&type=printable
    Download Restriction: no
    File URL: https://libkey.io/10.1371/journal.pone.0075284?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Kevin P Weinfurt & Damon M Seils & Janice P Tzeng & Li Lin & Kevin A Schulman & Robert M Califf, 2008. "Consistency of Financial Interest Disclosures in the Biomedical Literature: The Case of Coronary Stents," PLOS ONE, Public Library of Science, vol. 3(5), pages 1-7, May.
    2. Susan L Norris & Haley K Holmer & Lauren A Ogden & Shelley S Selph & Rongwei Fu, 2012. "Conflict of Interest Disclosures for Clinical Practice Guidelines in the National Guideline Clearinghouse," PLOS ONE, Public Library of Science, vol. 7(11), pages 1-8, November.
    3. Rosie Taylor & Jim Giles, 2005. "Cash interests taint drug advice," Nature, Nature, vol. 437(7062), pages 1070-1071, October.
    4. Adriane Fugh-Berman & Christina Pike McDonald & Alicia M Bell & Emily Catherine Bethards & Anthony R Scialli, 2011. "Promotional Tone in Reviews of Menopausal Hormone Therapy After the Women's Health Initiative: An Analysis of Published Articles," PLOS Medicine, Public Library of Science, vol. 8(3), pages 1-9, March.
    5. Susan L Norris & Haley K Holmer & Lauren A Ogden & Brittany U Burda, 2011. "Conflict of Interest in Clinical Practice Guideline Development: A Systematic Review," PLOS ONE, Public Library of Science, vol. 6(10), pages 1-6, October.
    Full references (including those not matched with items on IDEAS)

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Moriarty, Frank & Larkin, James & Fahey, Tom, 2021. "Payments reported by the pharmaceutical industry in Ireland from 2015 to 2019: An observational study," Health Policy, Elsevier, vol. 125(10), pages 1297-1304.
    2. Unruh, Lynn & Rice, Thomas & Rosenau, Pauline Vaillancourt & Barnes, Andrew J., 2016. "The 2013 cholesterol guideline controversy: Would better evidence prevent pharmaceuticalization?," Health Policy, Elsevier, vol. 120(7), pages 797-808.
    3. Emily Rickard & Piotr Ozieranski, 2021. "A hidden web of policy influence: The pharmaceutical industry’s engagement with UK’s All-Party Parliamentary Groups," PLOS ONE, Public Library of Science, vol. 16(6), pages 1-20, June.
    4. Cristina Morciano & Vittorio Basevi & Carla Faralli & Michele Hilton Boon & Sabina Tonon & Domenica Taruscio, 2016. "Policies on Conflicts of Interest in Health Care Guideline Development: A Cross-Sectional Analysis," PLOS ONE, Public Library of Science, vol. 11(11), pages 1-24, November.

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Susan L Norris & Haley K Holmer & Lauren A Ogden & Shelley S Selph & Rongwei Fu, 2012. "Conflict of Interest Disclosures for Clinical Practice Guidelines in the National Guideline Clearinghouse," PLOS ONE, Public Library of Science, vol. 7(11), pages 1-8, November.
    2. Joanne Khabsa & Jennifer Petkovic & Alison Riddle & Lyubov Lytvyn & Olivia Magwood & Pearl Atwere & Pauline Campbell & Srinivasa V. Katikireddi & Bronwen Merner & Mona Nasser & Stephanie Chang & Aleja, 2022. "PROTOCOL: Conflict of interest issues when engaging stakeholders in health and healthcare guideline development: a systematic review," Campbell Systematic Reviews, John Wiley & Sons, vol. 18(2), June.
    3. Tanya Graham & Phil Alderson & Tim Stokes, 2015. "Managing Conflicts of Interest in the UK National Institute for Health and Care Excellence (NICE) Clinical Guidelines Programme: Qualitative Study," PLOS ONE, Public Library of Science, vol. 10(3), pages 1-10, March.
    4. Susan L Norris & Haley K Holmer & Brittany U Burda & Lauren A Ogden & Rongwei Fu, 2012. "Conflict of Interest Policies for Organizations Producing a Large Number of Clinical Practice Guidelines," PLOS ONE, Public Library of Science, vol. 7(5), pages 1-12, May.
    5. Cristina Morciano & Vittorio Basevi & Carla Faralli & Michele Hilton Boon & Sabina Tonon & Domenica Taruscio, 2016. "Policies on Conflicts of Interest in Health Care Guideline Development: A Cross-Sectional Analysis," PLOS ONE, Public Library of Science, vol. 11(11), pages 1-24, November.
    6. Alemayehu Demissie & Levenstein Marcia, 2011. "Toward a Pragmatic Policy on Authorship," Statistics, Politics and Policy, De Gruyter, vol. 2(1), pages 1-12, October.
    7. Victoria S S Wong & Lauro Nathaniel Avalos & Michael L Callaham, 2019. "Industry payments to physician journal editors," PLOS ONE, Public Library of Science, vol. 14(2), pages 1-11, February.
    8. Damien Wyssa & Martin R Tramèr & Nadia Elia, 2019. "Reporting of conflicts of interest and of sponsorship of guidelines in anaesthesiology. A cross-sectional study," PLOS ONE, Public Library of Science, vol. 14(2), pages 1-13, February.
    9. Lisa Bero, 2018. "Meta-research matters: Meta-spin cycles, the blindness of bias, and rebuilding trust," PLOS Biology, Public Library of Science, vol. 16(4), pages 1-4, April.
    10. Joseph Pozsgai-Alvarez & Iván Pastor Sanz, 2021. "Mapping the (anti-)corruption field: key topics and changing trends, 1968–2020," Journal of Computational Social Science, Springer, vol. 4(2), pages 851-881, November.
    11. Unruh, Lynn & Rice, Thomas & Rosenau, Pauline Vaillancourt & Barnes, Andrew J., 2016. "The 2013 cholesterol guideline controversy: Would better evidence prevent pharmaceuticalization?," Health Policy, Elsevier, vol. 120(7), pages 797-808.
    12. Jeffrey Sonis & Olivia M Chen, 2020. "Approval processes in evidence-based clinical practice guidelines sponsored by medical specialty societies," PLOS ONE, Public Library of Science, vol. 15(2), pages 1-9, February.
    13. Zhuoqiong (Charlie) Chen & Tobias Gesche, 2016. "Persistent bias in advice-giving," ECON - Working Papers 228, Department of Economics - University of Zurich, revised Oct 2017.
    14. David Pontille & Didier Torny, 2013. "Behind the scenes of scientific articles: defining categories of fraud and regulating cases," CSI Working Papers Series 031, Centre de Sociologie de l'Innovation (CSI), Mines ParisTech.
    15. Susan L Norris & Haley K Holmer & Lauren A Ogden & Brittany U Burda, 2011. "Conflict of Interest in Clinical Practice Guideline Development: A Systematic Review," PLOS ONE, Public Library of Science, vol. 6(10), pages 1-6, October.
    16. Wang, Zhicheng & Bero, Lisa & Grundy, Quinn, 2021. "Understanding professional stakeholders’ active resistance to guideline implementation: The case of Canadian breast screening guidelines," Social Science & Medicine, Elsevier, vol. 269(C).
    17. Brian J Piper & Hassenet M Telku & Drew A Lambert, 2015. "A Quantitative Analysis of Undisclosed Conflicts of Interest in Pharmacology Textbooks," PLOS ONE, Public Library of Science, vol. 10(7), pages 1-9, July.
    18. Luca Iaboli & Luana Caselli & Angelina Filice & Gianpaolo Russi & Eleonora Belletti, 2010. "The Unbearable Lightness of Health Science Reporting: A Week Examining Italian Print Media," PLOS ONE, Public Library of Science, vol. 5(3), pages 1-6, March.
    19. Yidan Lu & Derek J Jones & Nour Sharara & Tonya Kaltenbach & Loren Laine & Kenneth McQuaid & Roy Soetikno & Venkataraman Subramanian & Alan Barkun, 2017. "Transparency ethics in practice: Revisiting financial conflicts of interest disclosure forms in clinical practice guidelines," PLOS ONE, Public Library of Science, vol. 12(8), pages 1-11, August.
    20. MinFang Tao & YinCheng Teng & HongFang Shao & Ping Wu & Edward J Mills, 2011. "Knowledge, Perceptions and Information about Hormone Therapy (HT) among Menopausal Women: A Systematic Review and Meta-Synthesis," PLOS ONE, Public Library of Science, vol. 6(9), pages 1-10, September.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:plo:pone00:0075284. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: plosone (email available below). General contact details of provider: https://journals.plos.org/plosone/ .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.